Document is current
Any future updates will be listed below
-
Authors
Abrigo, Johanna
Olguín, Hugo
Tacchi, Franco
Orozco-Aguilar, Josué
Valero-Breton, Mayalen
Soto, Jorge
Castro-Sepúlveda, Mauricio
Elorza, Alvaro A.
Simon, Felipe
Cabello-Verrugio, Claudio https://orcid.org/0000-0001-7273-2102
-
Funding
Funding for this research was provided by:
Fondo Nacional de Desarrollo Científico y Tecnológico (1200944, 1201039, 1180983)
Agencia Nacional de Investigación y Desarrollo (ANID) - Millennium Science Initiative Program (ICN09_016 / ICN 2021_045: Millennium Institute on Immunology, Immunotherapy (ICN09_016 / ICN 2021_045, former P09/016-F)
BASAL Grant – CEDENNA from the National Research and Development Agency (ANID), Government of Chile (AFB180001)
Millennium Nucleus of Ion Channel-Associated Diseases (Iniciativa Científica Milenio (ANID, Chile))
- License Information
-
More Information
Article History
Received: 17 August 2022
Accepted: 27 April 2023
First Online: 8 June 2023
Declarations
:
: Animal handling and treatments followed international, national, and institutional suggestions explicit in animal care and use guidelines. The procedures with animals had the Animal Ethics Committee’s approval at the Universidad Andrés Bello (approval number 004/2020).
: Not applicable.
: The authors declare that they have no competing interests.
